Basic information Safety Supplier Related

2-GUANIDINOETHYLMERCAPTOSUCCINIC ACID

Basic information Safety Supplier Related

2-GUANIDINOETHYLMERCAPTOSUCCINIC ACID Basic information

Product Name:
2-GUANIDINOETHYLMERCAPTOSUCCINIC ACID
Synonyms:
  • 2-GUANIDINOETHYLMERCAPTOSUCCINIC ACID
  • GUANIDINOETHYLMERCAPTO-SUCCINIC ACID
  • GEMSA
  • (2-GUANIDINOETHYLMERCAPTO)SUCCINIC ACID 99+%
  • (2-Guanidinoethylthio)succinic acid, GEMSA
  • 2-(2-Guanidinoethylthio)succinic acid
  • 2-[(2-Guanidinoethyl)thio]succinic acid
  • 2-Guanidinoethylthiosuccinic acid
CAS:
77482-44-1
MF:
C7H13N3O4S
MW:
235.26
Mol File:
77482-44-1.mol
More
Less

2-GUANIDINOETHYLMERCAPTOSUCCINIC ACID Chemical Properties

Melting point:
~180 °C (dec.)
storage temp. 
2-8°C
solubility 
Soluble in DMSO
form 
White solid
More
Less

Safety Information

Safety Statements 
22-24/25
More
Less

2-GUANIDINOETHYLMERCAPTOSUCCINIC ACID Usage And Synthesis

Biological Activity

ki: 8.8 nm2-guanidinoethylmercaptosuccinic acid is a carboxypeptidase e inhibitor.carboxypeptidase e, also known as enkephalin convertase, can remove c-terminal residues during the processing of propeptides, such as enkephalin and proinsulin.

in vitro

2-guanidinoethylmercaptosuccinic acid was identified as a biproduct analogs of lysine and arginine that showed potent inhibitory effect on enkephalin convertase with the ki value of 8.8 nm. in addition, 2-guanidinoethylmercaptosuccinic acid was found to be several hundred fold more potent towards enkephalin convertase than towards carboxypeptidase b or n and the kinetic analyses indicated the pure competitive nature of the inhibition [1].

in vivo

previous study found that following the intrathecal administration of 2-guanidinoethylmercaptosuccinic acid at 12.5, 25 and 50 micrograms, an increase in the tail-flick latency was seen. in addition, 2-guanidinoethylmercaptosuccinic acid could potentiate the analgesic effects of the intrathecally applied met5-enkephalin-arg6-phe7 and met5-enkephalin-arg6-gly7-leu8. all these effects of 2-guanidinoethylmercaptosuccinic acid were significantly attenuated by the treatment of naloxone. moreover, the rats subjected to chronic pain showed a weaker analgesic response to the treatment of 2-guanidinoethylmercaptosuccinic acid. furthermore, 2-guanidinoethylmercaptosuccinic acid bound to enkephalin convertase in the spinal cord of these rats produced only a slight increase in kd [2].

References

1. fricker ld, plummer th jr, snyder sh. enkephalin convertase: potent, selective, and irreversible inhibitors. biochem biophys res commun. 1983 mar 29;111(3):994-1000.2. m. bommer, k. nikolarakis, e. p. noble, et al. in vivo modulation of rat hypothalamic opioid peptide content by intracerebroventricular injection of guanidinoethylmercaptosuccinic acid (gemsa): possible physiological role of enkephalin convertase. brain research 492(1-2), 305-313 (1989).

2-GUANIDINOETHYLMERCAPTOSUCCINIC ACIDSupplier

BOC Sciences
Tel
16314854226
Email
info@bocsci.com
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Email
info@efebio.com
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
Tel
18818260767
Email
sales@chemegen.com
MedBioPharmaceutical Technology Inc
Tel
021-69568360 18916172912
Email
order@med-bio.cn
TargetMol Chemicals Inc.
Tel
4008200310
Email
marketing@tsbiochem.com